Overview
Rozlytrek is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancerous tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known resistance…

Overview
Rubraca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adult patients with recurrent epithelial ovarian cancer who are in a complete or partial…

Overview
Vitrakvi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known resistance…

Overview
Zejula is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adults with advanced or recurrent epithelial ovarian cancer who are in a complete or partial…